Episode 30: CASIINDEV & COVID-19

NECA in the Know

Oct 07, 2021•17 min•Ep. 30

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

This week we sat down with John Faragon to talk about the use of casirivimab and imdevimab as post-exposure prevention of COVID-19. Learn about who would benefit from this drug combination, when to administer it, and everything healthcare providers need to know.

--

Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)

--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.

--
Check out our free online courses: www.necaaetc.org/rise-courses

--
Download our HIV mobile apps:

Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US

Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

For the best experience, listen in Metacast app for iOS or Android